What is it about?
Are discharge prescriptions of oral anticoagulants relevant to the respective stroke risk of the patients? What about the particular OACs, namely VKAs and NOACs? Are VKA prescriptions sufficiently going to reach the INR target in the long run? Are NOACs dosed according to each drug's labelling?
Featured Image
Why is it important?
Given AF's increasingly high prevalence among discharged patients, clinicians should become adept at administering OAC concordantly to the corresponding stroke risk and at selecting the right Oral Anticoagulant for the right patient, including proper dosage for NOACs. Common errors in real-world practice are outlined in this paper, based on the largest AF database in Greece. Readers will often identify themselves with these errors and learn which factors most often precipitate them.
Perspectives
This is a comprehensive and 'merciless' retrospective analysis of real-world OAC strategies in AF applied in a tertiary-centre, pinpointing many do's and don't when handling this so common comorbidity.
Dr Anastasios Kartas
Aristotle University of Thessaloniki
Read the Original
This page is a summary of: Flaws in Anticoagulation Strategies in Patients With Atrial Fibrillation at Hospital Discharge, Journal of Cardiovascular Pharmacology and Therapeutics, January 2019, SAGE Publications,
DOI: 10.1177/1074248418821712.
You can read the full text:
Resources
Contributors
The following have contributed to this page
